α-1-tributyltin-o-2,3-bisacety1-4,6-ethylidene-glucose as a convenient glycosidation reagent: An efficient synthesis of etoposide

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

The antineoplastic drug etoposide has been prepared by a chemically and operationally simple process. The salient reaction is the BF3·etherate promoted, room temperature condensation of 4′-demethyl-4′-acetyl-epipodophyllotoxin 4, with α-1-Bu3Sn-O-2,3-bisacetyl-4,6-ethylidene-glucose 6. The latter compound was prepared from 4,6-β-ethylidene glucose triacetate and Bu3Sn-OMe obtained in situ from (Bu3Sn)2O and dimethyl carbonate. A readily separable mixture of α and β-etoposide triacetate epimers was obtained where the desired β-epimer predominated. In contrast, 4,6-α-ethylidene glucose diacetate and 4, even at O°C, gave an equimolar mixture of epimers. It is proposed that the stereochemical outcome may be attributed to electronic effects in the activated tin-glucose reagent.

Original languageEnglish
Pages (from-to)3049-3056
Number of pages8
JournalTetrahedron
Volume52
Issue number8
DOIs
StatePublished - 1996

Fingerprint

Dive into the research topics of 'α-1-tributyltin-o-2,3-bisacety1-4,6-ethylidene-glucose as a convenient glycosidation reagent: An efficient synthesis of etoposide'. Together they form a unique fingerprint.

Cite this